Our study on chromatin states in metastatic melanoma came out today. We demonstrate genotype-specific chromatin state patterns and suggest use of PRC2 inhibitors in NRAS-mutant melanoma.
cell.com/cell-reports/fullte…@tangming2005 Chris Terranova Mahinur Maitituoheti
@MDAndersonNews
Our manuscript showing tumor suppressor function of KMT2D in melanoma is out today in Cell Reports.
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma cell.com/cell-reports/fullte…